Reliant Pharmaceuticals Inc has warned pharmacists about recent confusion between its Omacor (omega-3-acid ethyl esters) capsules and Xanodyne Pharmaceuticals Inc's Amicar (aminocaproic acid) tablets. Omacor's manufacturer has informed pharmacists that telephone orders for its drug continue to be "misunderstood and dispensed" as Amicar.
FDA-approved Omacor is indicated as an adjunct to diet for the reduction of very high triglyceride levels. Amicar, however, is indicated for enhancing hemostasis when fibrinolysis contributes to bleeding. In certain patients, Amicar is prescribed for oral use to control acute or chronic bleeding syndromes.
Reliant issued a similar warning in November 2005. The company said that it was developing a "shelf talker" for pharmacists "to help prevent any more medication errors." For more information, visit www.omacorrx.com.
One study linked multiple pregnancies to an increased risk of developing atrial fibrillation later in life, and another investigated the association between premature delivery and cardiovascular disease.
Clinical features with downloadable PDFs